Market Cap 62.78M
Revenue (ttm) 0.00
Net Income (ttm) -11.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 11,700
Avg Vol 51,530
Day's Range N/A - N/A
Shares Out 49.05M
Stochastic %K 14%
Beta 0.43
Analysts Strong Sell
Price Target $8.00

Company Profile

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical my...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 373 1500
Fax: 858 404 0048
Address:
4275 Executive Square, Suite 300, La Jolla, United States
DARKP00L
DARKP00L Sep. 8 at 2:05 PM
$MNOV 09:12 on Sep. 08 2025 MediciNova Issues Shareholder Update; Secures $30M SEPA To Advance R&D As COMBAT-ALS Trial Hits Enrollment Target; NIH-Funded EAP And MN-001 Diabetes Study Near Completion #tradeideas
0 · Reply
elmono
elmono Aug. 28 at 8:49 AM
$MNOV ceo was lying through his teeth about patent reward. Too funny really that he gets away with his statements….treating investors like shit. No good😂😂
1 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Aug. 27 at 1:09 PM
🌞🌞 watchlist part 2 ✅️ $MNOV 1.40 support, if above 1.50, have potential to 1.70/.80 ✅️ $SLRX mid 5.50 support, if above 6, have potential to 6.30/6.50 ✅️ $VSME 1.70 support, ideal if above 2, if above 2.20, have potential to 2.50/.60 ✅️ $OPAD mid 3.50 support, if above 4.0, have potential to 4/4.30, recent high 5.20, up over 420% from swing 🚀🚀 CONGRATS if you got in during swing accumulation phase before/low 1 before the breakout , ✅️ $OPEN multi day runner, current support mid 4.50, if above 4.75, have potential to 5, CONGRATS if you got in below/low 2 during swing accumulation phase, recent high 5.85 today, up 192% from swing 🚀 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance ✅️ PLUG SCNX still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
thepalace2007
thepalace2007 Aug. 27 at 1:06 PM
$MNOV this will eventually be a grand slam buy and hold for the gold
0 · Reply
JarvisFlow
JarvisFlow Aug. 27 at 12:30 PM
D. Boral Capital has adjusted their stance on MediciNova ( $MNOV ), setting the rating to Buy with a target price of 9.
0 · Reply
Whiskey1679
Whiskey1679 Aug. 27 at 12:20 PM
$MNOV Currently at $1.37 This came out late yesterday https://www.stocktitan.net/news/MNOV/medici-nova-achieves-enrollment-in-combat-als-clinical-k42vs2knzazt.html $DVLT https://www.theglobeandmail.com/investing/markets/stocks/DVLT/pressreleases/34399330/datavault-ai-nasdaq-dvlt-expands-verifyu-platform-to-combat-stolen-valor-advance-military-identity-verification/ $DVLT Currently at 0.4297 https://ir.datavaultsite.com/news-events/press-releases/detail/348/datavault-ai-q2-2025-recognized-revenue-of-1-7m Premarket Gappers: $NBY $DSS $MDB
0 · Reply
palm3
palm3 Aug. 27 at 9:47 AM
$MNOV good time to buy
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Aug. 27 at 1:59 AM
🌞🌞watchlist part 1 ✅️ $BTAI low 6 support, if above 6.50, have potential to 6.80/.90, reveal top line data at 8am EST tomorrow for SERENITY At-Home pivotal phase 3 trial, the company's proprietary, sublingual film formulation of dexmedetomidine, as an acute treatment for agitation associated with bipolar disorders or schizophrenia in at-home setting ✅️ $DSS low 2 support, if above 2.60, have potential to 2.90/3, ✅️ $NBY low 1 support, if above 1.45, have potential to 1.70/.80, David E. Lazar 19.90% ✅️ $TTNP low 6 support, if above 6.50, have potential to 6.90/7, ultra small float <1m, approves merger with Black Titan, , expected to close Q3 ✅️ $MNOV 1.40 support, if above 1.50, have potential to 1.70/.80 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance ✅️ PLUG SCNX still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
thepalace2007
thepalace2007 Aug. 26 at 11:53 PM
$MNOV nice pop off news after hours
0 · Reply
TheTinyDevil
TheTinyDevil Aug. 26 at 11:22 PM
$MNOV Pretty big pop here AH...
0 · Reply
Latest News on MNOV
MediciNova Provides Shareholder Update on Key Developments

Sep 8, 2025, 9:00 AM EDT - 3 days ago

MediciNova Provides Shareholder Update on Key Developments


MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial

Aug 26, 2025, 7:00 PM EDT - 15 days ago

MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial


MediciNova Chief Business Officer David H. Crean, Ph.D.

Jun 20, 2024, 6:00 AM EDT - 1 year ago

MediciNova Chief Business Officer David H. Crean, Ph.D.


MediciNova Receives Gene Therapy Milestone Payment

Oct 4, 2023, 7:00 PM EDT - 2 years ago

MediciNova Receives Gene Therapy Milestone Payment


DARKP00L
DARKP00L Sep. 8 at 2:05 PM
$MNOV 09:12 on Sep. 08 2025 MediciNova Issues Shareholder Update; Secures $30M SEPA To Advance R&D As COMBAT-ALS Trial Hits Enrollment Target; NIH-Funded EAP And MN-001 Diabetes Study Near Completion #tradeideas
0 · Reply
elmono
elmono Aug. 28 at 8:49 AM
$MNOV ceo was lying through his teeth about patent reward. Too funny really that he gets away with his statements….treating investors like shit. No good😂😂
1 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Aug. 27 at 1:09 PM
🌞🌞 watchlist part 2 ✅️ $MNOV 1.40 support, if above 1.50, have potential to 1.70/.80 ✅️ $SLRX mid 5.50 support, if above 6, have potential to 6.30/6.50 ✅️ $VSME 1.70 support, ideal if above 2, if above 2.20, have potential to 2.50/.60 ✅️ $OPAD mid 3.50 support, if above 4.0, have potential to 4/4.30, recent high 5.20, up over 420% from swing 🚀🚀 CONGRATS if you got in during swing accumulation phase before/low 1 before the breakout , ✅️ $OPEN multi day runner, current support mid 4.50, if above 4.75, have potential to 5, CONGRATS if you got in below/low 2 during swing accumulation phase, recent high 5.85 today, up 192% from swing 🚀 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance ✅️ PLUG SCNX still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
thepalace2007
thepalace2007 Aug. 27 at 1:06 PM
$MNOV this will eventually be a grand slam buy and hold for the gold
0 · Reply
JarvisFlow
JarvisFlow Aug. 27 at 12:30 PM
D. Boral Capital has adjusted their stance on MediciNova ( $MNOV ), setting the rating to Buy with a target price of 9.
0 · Reply
Whiskey1679
Whiskey1679 Aug. 27 at 12:20 PM
$MNOV Currently at $1.37 This came out late yesterday https://www.stocktitan.net/news/MNOV/medici-nova-achieves-enrollment-in-combat-als-clinical-k42vs2knzazt.html $DVLT https://www.theglobeandmail.com/investing/markets/stocks/DVLT/pressreleases/34399330/datavault-ai-nasdaq-dvlt-expands-verifyu-platform-to-combat-stolen-valor-advance-military-identity-verification/ $DVLT Currently at 0.4297 https://ir.datavaultsite.com/news-events/press-releases/detail/348/datavault-ai-q2-2025-recognized-revenue-of-1-7m Premarket Gappers: $NBY $DSS $MDB
0 · Reply
palm3
palm3 Aug. 27 at 9:47 AM
$MNOV good time to buy
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Aug. 27 at 1:59 AM
🌞🌞watchlist part 1 ✅️ $BTAI low 6 support, if above 6.50, have potential to 6.80/.90, reveal top line data at 8am EST tomorrow for SERENITY At-Home pivotal phase 3 trial, the company's proprietary, sublingual film formulation of dexmedetomidine, as an acute treatment for agitation associated with bipolar disorders or schizophrenia in at-home setting ✅️ $DSS low 2 support, if above 2.60, have potential to 2.90/3, ✅️ $NBY low 1 support, if above 1.45, have potential to 1.70/.80, David E. Lazar 19.90% ✅️ $TTNP low 6 support, if above 6.50, have potential to 6.90/7, ultra small float <1m, approves merger with Black Titan, , expected to close Q3 ✅️ $MNOV 1.40 support, if above 1.50, have potential to 1.70/.80 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance ✅️ PLUG SCNX still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
thepalace2007
thepalace2007 Aug. 26 at 11:53 PM
$MNOV nice pop off news after hours
0 · Reply
TheTinyDevil
TheTinyDevil Aug. 26 at 11:22 PM
$MNOV Pretty big pop here AH...
0 · Reply
dbr_island
dbr_island Aug. 26 at 11:09 PM
$MNOV there it goes HERZ is next and has MAJOR gaps to fill👇🚨 WATCH AND LEARN
0 · Reply
All_Nothing
All_Nothing Aug. 1 at 2:59 PM
$MNOV MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million. 3% purchase discount for the next 3 years. https://investors.medicinova.com/node/13216/html
2 · Reply
All_Nothing
All_Nothing Jul. 25 at 6:25 PM
$MNOV finally some good news. Now how about some information on the monetary damages!?
0 · Reply
Corpius
Corpius Jul. 25 at 4:20 PM
$MNOV interesting buys and volume. no news. insider buys before big PR?
0 · Reply
hitmongreen
hitmongreen Jul. 24 at 5:10 PM
$MNOV 🤔
0 · Reply
Lionish
Lionish Jul. 24 at 2:33 PM
$MNOV Make sure you are invested and be patient…
1 · Reply
JarvisFlow
JarvisFlow Jul. 24 at 1:00 PM
D. Boral Capital has updated their rating for MediciNova ( $MNOV ) to Buy with a price target of 9.
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 24 at 10:25 AM
$MNOV pt 1.5
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 24 at 10:24 AM
$MNOV MediciNova is nearing full enrollment in both the ALS and metabolic/lipid trials, marking important milestones toward readouts—potentially late 2026 for ALS and mid‑term outcomes for the MN‑001 metabolic study.
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 24 at 10:14 AM
$MNOV MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials By MediciNova, Inc. | July 24, 2025, 6:00 AM
0 · Reply
blz90
blz90 Jul. 23 at 7:42 AM
$MNOV This is dead.
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 5:35 PM
B. Riley Securities has updated their rating for MediciNova ( $MNOV ) to Buy with a price target of 5.
0 · Reply